WHITEPAPER: TELEMONITORING
Is the Telemonitoring DiGA Coming? An Analysis of Reimbursement Routes, Hurdles, and Opportunities (2026)
Presentation by QuickBird Medical at Pharma Deutschland
Contents
- Update April 2026 following the GeDIG draft bill
- The Telemonitoring Landscape in Germany: EBM (uniform fee schedule), selective contracts, and the Innovation Fund (Innovationsfonds)
- DiGA Directory: Why there is no genuine telemonitoring DiGA yet
- Regulatory, Economic, and Technical Hurdles for a telemonitoring DiGA
- Practical Recommendations: What manufacturers who still plan one should consider
- Outlook: Is the telemonitoring DiGA coming, or are there better routes to reimbursement?
promises better care for chronically ill patients through remote monitoring of vital signs. But what does the reality of reimbursement in Germany actually look like?
On this topic, QuickBird Medical Managing Director Malte Bucksch gave a short talk at the DiGA working group of Pharma Deutschland.
Since March 2024, the Digital Act (DigiG) has opened risk class IIb to DiGA. In theory, this would clear the way for a telemonitoring DiGA. In practice, however, a number of hurdles stand in the way and must be overcome. In April 2026, the “Gesetz für Daten und digitale Innovation im Gesundheitswesen” (GeDIG, Act on Data and Digital Innovation in Healthcare) provides further specifics.
In this presentation, Malte Bucksch analyzes the current telemonitoring landscape in Germany, shows why there is no genuine telemonitoring DiGA in the BfArM directory yet and whether the first telemonitoring DiGA will arrive soon


